Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 31 Neoplasms 8 Endometrial Neoplasms 6 Neoplasm Metastasis 5 Brain Neoplasms 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Head and Neck Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Meningioma 3 Glioblastoma 3 Sarcoma 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Lymphoma, Non-Hodgkin 2 Carcinoma, Non-Small-Cell Lung 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Retinoblastoma 1 Recurrence 1 Pathologic Complete Response 1 Osteosarcoma 1 Neoplasms, Squamous Cell 1 Neoplasm, Residual 1 Multiple Myeloma 1

Interventions

Cyclophosphamide 41 fludarabine 35 Tacrolimus 28 Mycophenolic Acid 27 Whole-Body Irradiation 25 Busulfan 24 fludarabine phosphate 21 Melphalan 19 thymoglobulin 16 Antilymphocyte Serum 16 Methotrexate 13 Thiotepa 12 Stem Cell Transplantation 9 Rituximab 9 Granulocyte Colony-Stimulating Factor 9 Filgrastim 8 Cyclosporine 8 trametinib 7 Sirolimus 7 Nivolumab 5 ruxolitinib 4 merphos 4 Peripheral Blood Stem Cell Transplantation 4 Cytarabine 4 Cord Blood Stem Cell Transplantation 4 Bendamustine Hydrochloride 4 tocilizumab 3 itacitinib 3 fedratinib 3 dabrafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hematologic Neoplasms × abemaciclib × Clear all

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡